REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 307 filers reported holding REPLIGEN CORP in Q4 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $261,077 | -23.4% | 1,542 | -15.3% | 0.00% | -100.0% |
| Q3 2022 | $341,000 | -22.5% | 1,820 | -32.8% | 0.00% | 0.0% |
| Q2 2022 | $440,000 | +2.3% | 2,707 | -41.8% | 0.00% | 0.0% |
| Q4 2019 | $430,000 | -93.2% | 4,650 | -94.4% | 0.00% | -94.1% |
| Q3 2019 | $6,324,000 | -12.6% | 82,460 | -2.0% | 0.02% | -10.5% |
| Q2 2019 | $7,234,000 | +1547.8% | 84,160 | +1032.7% | 0.02% | +1800.0% |
| Q1 2019 | $439,000 | -98.7% | 7,430 | -99.2% | 0.00% | -98.9% |
| Q1 2018 | $34,240,000 | +0.4% | 946,366 | +0.7% | 0.09% | +6.1% |
| Q4 2017 | $34,106,000 | +548.6% | 940,066 | +585.1% | 0.08% | +192.9% |
| Q3 2017 | $5,258,000 | -26.0% | 137,218 | -32.0% | 0.03% | -33.3% |
| Q1 2017 | $7,107,000 | +48.2% | 201,917 | +29.8% | 0.04% | +44.8% |
| Q4 2016 | $4,796,000 | – | 155,617 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |